Discontinued Operations - Schedule of Consolidated Statements of Discontinued Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Restructuring charges	$ 6,180
Annoveras | Discontinued Operations
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Revenue from transaction	80,749	$ 84,378
Cost of goods sold	15,640	17,436
Gross profit	65,109	66,942
Operating expenses:
Selling and marketing	75,208	108,195
General and administrative	11,301	11,854
Research and development	4,942	7,086
Restructuring charges	6,180
Total operating expenses	97,631	127,135
Loss from discontinued operations	(32,522)	(60,193)
Other (expense) income:
Gain on sale of vitaCare	143,384
Gain on ANNOVERA sale	62,031
Loss on the extinguishment of debt	(8,380)
Interest expense and other financing costs	(36,065)	(32,917)
Expense for accretion of Series A Preferred Stock	(16,973)
Total other income (expense), net	143,997	(32,917)
Loss before from income taxes	111,475	(93,110)
Provision for income taxes	(552)
Net income (loss) from discontinued operations	$ 110,923	$ (93,110)